E-selectin is a calcium-dependent, transmembrane glycoprotein that plays a critical role in vascular pathophysiology by mediating leukocyte adhesion and migration. It is primarily expressed in endothelial cells and is upregulated by pro-inflammatory cytokines. E-selectin interacts with ligands on circulating leukocytes, facilitating their adhesion, migration, and activation. Oxidative stress can induce aberrant E-selectin expression, contributing to vascular injury and inflammation. E-selectin dysregulation is associated with various diseases, including acute kidney injury, pulmonary diseases, hepatic pathology, and venous thromboembolism. Mice lacking E-selectin show reduced complications in these conditions, suggesting its therapeutic potential. E-selectin's physiological functions include facilitating leukocyte adhesion, migration, and homing of hematopoietic stem cells to the bone marrow. It also plays a role in endothelial progenitor cell migration and tissue repair. In disease states, elevated sE-selectin levels are linked to inflammation and disease progression. The regulation of E-selectin expression involves multiple transcription factors, including NF-κB, ATF2, and ERG, which are influenced by inflammatory signals and oxidative stress. E-selectin interacts with various ligands, such as PSGL-1, CD44, and ESL-1, which are crucial for leukocyte recruitment and inflammatory responses. These interactions are mediated through specific binding sites and influence cellular signaling pathways. Therapeutic approaches targeting E-selectin include monoclonal antibodies, small molecule inhibitors, and microRNAs that modulate E-selectin expression or activity. These strategies aim to reduce inflammation, vascular leakage, and cancer metastasis by inhibiting E-selectin function. In summary, E-selectin is a key player in vascular inflammation and disease. Its regulation and modulation offer potential therapeutic avenues for treating various inflammatory and vascular disorders. Further research is needed to fully understand its role in disease pathogenesis and to develop effective therapeutic interventions.E-selectin is a calcium-dependent, transmembrane glycoprotein that plays a critical role in vascular pathophysiology by mediating leukocyte adhesion and migration. It is primarily expressed in endothelial cells and is upregulated by pro-inflammatory cytokines. E-selectin interacts with ligands on circulating leukocytes, facilitating their adhesion, migration, and activation. Oxidative stress can induce aberrant E-selectin expression, contributing to vascular injury and inflammation. E-selectin dysregulation is associated with various diseases, including acute kidney injury, pulmonary diseases, hepatic pathology, and venous thromboembolism. Mice lacking E-selectin show reduced complications in these conditions, suggesting its therapeutic potential. E-selectin's physiological functions include facilitating leukocyte adhesion, migration, and homing of hematopoietic stem cells to the bone marrow. It also plays a role in endothelial progenitor cell migration and tissue repair. In disease states, elevated sE-selectin levels are linked to inflammation and disease progression. The regulation of E-selectin expression involves multiple transcription factors, including NF-κB, ATF2, and ERG, which are influenced by inflammatory signals and oxidative stress. E-selectin interacts with various ligands, such as PSGL-1, CD44, and ESL-1, which are crucial for leukocyte recruitment and inflammatory responses. These interactions are mediated through specific binding sites and influence cellular signaling pathways. Therapeutic approaches targeting E-selectin include monoclonal antibodies, small molecule inhibitors, and microRNAs that modulate E-selectin expression or activity. These strategies aim to reduce inflammation, vascular leakage, and cancer metastasis by inhibiting E-selectin function. In summary, E-selectin is a key player in vascular inflammation and disease. Its regulation and modulation offer potential therapeutic avenues for treating various inflammatory and vascular disorders. Further research is needed to fully understand its role in disease pathogenesis and to develop effective therapeutic interventions.